DK0778023T3 - Produkt indeholdende rapamycin eller udvalgte derivater deraf og en NMDA- eller AMPA-antagonist til anvendelse ved behandling af epilepsi eller Huntingtons sygdom, og anvendelse af rapamycin eller udvalgte derivater deraf..... - Google Patents
Produkt indeholdende rapamycin eller udvalgte derivater deraf og en NMDA- eller AMPA-antagonist til anvendelse ved behandling af epilepsi eller Huntingtons sygdom, og anvendelse af rapamycin eller udvalgte derivater deraf.....Info
- Publication number
- DK0778023T3 DK0778023T3 DK96308786T DK96308786T DK0778023T3 DK 0778023 T3 DK0778023 T3 DK 0778023T3 DK 96308786 T DK96308786 T DK 96308786T DK 96308786 T DK96308786 T DK 96308786T DK 0778023 T3 DK0778023 T3 DK 0778023T3
- Authority
- DK
- Denmark
- Prior art keywords
- rapamycin
- selected derivatives
- nmda
- huntington
- epilepsy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US833795P | 1995-12-07 | 1995-12-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0778023T3 true DK0778023T3 (da) | 2003-06-30 |
Family
ID=21731060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96308786T DK0778023T3 (da) | 1995-12-07 | 1996-12-04 | Produkt indeholdende rapamycin eller udvalgte derivater deraf og en NMDA- eller AMPA-antagonist til anvendelse ved behandling af epilepsi eller Huntingtons sygdom, og anvendelse af rapamycin eller udvalgte derivater deraf..... |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0778023B1 (cs) |
| JP (1) | JPH09183727A (cs) |
| KR (1) | KR970032856A (cs) |
| CN (1) | CN1112925C (cs) |
| AR (1) | AR008747A1 (cs) |
| AT (1) | ATE234095T1 (cs) |
| AU (1) | AU700653B2 (cs) |
| BR (1) | BR9605895A (cs) |
| CA (1) | CA2192298A1 (cs) |
| CZ (2) | CZ6498A3 (cs) |
| DE (1) | DE69626610T2 (cs) |
| DK (1) | DK0778023T3 (cs) |
| ES (1) | ES2188730T3 (cs) |
| HU (1) | HUP9603370A3 (cs) |
| IL (1) | IL119778A (cs) |
| MX (1) | MX9606131A (cs) |
| NO (1) | NO309966B1 (cs) |
| NZ (1) | NZ299888A (cs) |
| PT (1) | PT778023E (cs) |
| SI (1) | SI0778023T1 (cs) |
| SK (1) | SK154796A3 (cs) |
| TW (1) | TW427904B (cs) |
| ZA (1) | ZA9610245B (cs) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1002535A1 (en) | 1998-10-28 | 2000-05-24 | Hrissanthi Ikonomidou | New use of glutamate antagonists for the treatment of cancer |
| US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
| US6417189B1 (en) * | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
| FR2806626B1 (fr) * | 2000-03-22 | 2003-11-28 | Centre Nat Rech Scient | Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues |
| WO2001079177A1 (en) * | 2000-04-17 | 2001-10-25 | Gpi Nil Holdings, Inc. | Cyclic diaza compounds for treating neurodegenerative disorders |
| GB0117645D0 (en) | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
| UA78529C2 (en) * | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
| US20030176455A1 (en) * | 2002-03-13 | 2003-09-18 | Wyeth | Method of inhibiting cell death |
| CA2521394A1 (en) * | 2003-04-09 | 2004-10-28 | Wyeth | Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof |
| ATE481103T1 (de) | 2003-04-09 | 2010-10-15 | Wyeth Llc | Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten |
| US20070155771A1 (en) * | 2003-04-11 | 2007-07-05 | David Rubinsztein | Methods and means for treating protein conformational disorders |
| US7485706B2 (en) * | 2003-07-30 | 2009-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Neurodegenerative protein aggregation inhibition methods and compounds |
| TW200514775A (en) | 2003-10-22 | 2005-05-01 | Wyeth Corp | Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof |
| NZ574663A (en) * | 2004-12-20 | 2010-05-28 | Wyeth Corp | Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
| RU2007119585A (ru) | 2004-12-20 | 2009-01-27 | Вайет (Us) | Производные рапамицина и их применение при лечении неврологических заболеваний |
| JP4857071B2 (ja) * | 2006-10-12 | 2012-01-18 | 潤平 笹部 | 筋萎縮性側策硬化症（ａｌｓ）の検出方法 |
| EP2065038A1 (en) | 2007-11-30 | 2009-06-03 | Pharnext | New therapeutic approaches for treating Charcot-Marie-Tooth disease |
| EP2135607A1 (en) | 2008-06-18 | 2009-12-23 | Pharnext | Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders |
| BRPI1010655A2 (pt) * | 2009-04-10 | 2019-09-03 | Qi Haiyan | novos agentes antienvelhecimento e métodos para identificá-los |
| EP2263665A1 (en) | 2009-06-02 | 2010-12-22 | Pharnext | New compositions for treating CMT and related disorders |
| US9393241B2 (en) | 2009-06-02 | 2016-07-19 | Pharnext | Compositions for treating CMT and related disorders |
| EP2456437A4 (en) * | 2009-07-24 | 2013-01-09 | Inst Nat Rech Scient | COMBINATIONS OF CURCUMOIDENE AND MTOR INHIBITORS FOR THE TREATMENT OF TAUOPATHIES |
| US9121859B2 (en) * | 2012-12-04 | 2015-09-01 | Siemens Healthcare Diagnostics Inc. | Compounds and methods for determination of FKBP-binding immunosuppressant drugs |
| DK3003268T3 (en) | 2013-06-05 | 2018-11-05 | Pharnext | STABLE ORAL SOLUTIONS FOR COMBINED API |
| US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
| US10383870B2 (en) | 2016-06-10 | 2019-08-20 | Pharnext | Early treatment of CMT disease |
| AU2018369912A1 (en) * | 2017-11-15 | 2020-05-28 | Vanderbilt University | Methods and compositions for the improvement of lysosomal function and treatment of neurodegenerative disease |
| CN114366738A (zh) * | 2021-12-20 | 2022-04-19 | 中国人民解放军军事科学院军事医学研究院 | 雷帕霉素在促进神经干细胞扩增中的用途 |
| CN119639757B (zh) * | 2024-12-11 | 2025-07-22 | 庐山市绿游生态农业开发有限公司 | 一种红藻氨酸受体及其抑制剂在防治橘小实蝇中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206018A (en) * | 1978-11-03 | 1993-04-27 | Ayerst, Mckenna & Harrison, Inc. | Use of rapamycin in treatment of tumors |
| JPH04230389A (ja) * | 1990-07-16 | 1992-08-19 | American Home Prod Corp | ラパマイシン誘導体 |
| US5078999A (en) * | 1991-02-22 | 1992-01-07 | American Home Products Corporation | Method of treating systemic lupus erythematosus |
| IL101353A0 (en) * | 1991-04-03 | 1992-11-15 | American Home Prod | Pharmaceutical compositions for treating diabetes |
| DE4118740A1 (de) * | 1991-06-05 | 1992-12-10 | Schering Ag | Neue kombinationspraeparate zur behandlung des morbus parkinson |
| ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
| US5260299A (en) * | 1992-03-05 | 1993-11-09 | American Home Products Corporation | Rapamycin 42-sulfonates and 42-(N-Carboalkoxy)Sulfamates Useful as Immunosuppressive Agents |
| IL111003A0 (en) * | 1993-09-30 | 1994-11-28 | American Home Prod | Multi-component oral rapamycin formulation |
-
1996
- 1996-11-28 TW TW085114700A patent/TW427904B/zh not_active IP Right Cessation
- 1996-12-04 DK DK96308786T patent/DK0778023T3/da active
- 1996-12-04 ES ES96308786T patent/ES2188730T3/es not_active Expired - Lifetime
- 1996-12-04 SK SK1547-96A patent/SK154796A3/sk unknown
- 1996-12-04 PT PT96308786T patent/PT778023E/pt unknown
- 1996-12-04 CZ CZ9864A patent/CZ6498A3/cs unknown
- 1996-12-04 SI SI9630586T patent/SI0778023T1/xx unknown
- 1996-12-04 CZ CZ963544A patent/CZ354496A3/cs unknown
- 1996-12-04 AT AT96308786T patent/ATE234095T1/de not_active IP Right Cessation
- 1996-12-04 DE DE69626610T patent/DE69626610T2/de not_active Expired - Fee Related
- 1996-12-04 EP EP96308786A patent/EP0778023B1/en not_active Expired - Lifetime
- 1996-12-05 AU AU74178/96A patent/AU700653B2/en not_active Ceased
- 1996-12-05 MX MX9606131A patent/MX9606131A/es unknown
- 1996-12-05 NZ NZ299888A patent/NZ299888A/en unknown
- 1996-12-05 KR KR1019960062011A patent/KR970032856A/ko not_active Ceased
- 1996-12-05 ZA ZA9610245A patent/ZA9610245B/xx unknown
- 1996-12-06 CA CA002192298A patent/CA2192298A1/en not_active Abandoned
- 1996-12-06 AR ARP960105543A patent/AR008747A1/es not_active Application Discontinuation
- 1996-12-06 HU HU9603370A patent/HUP9603370A3/hu unknown
- 1996-12-06 NO NO965238A patent/NO309966B1/no not_active IP Right Cessation
- 1996-12-06 JP JP8326582A patent/JPH09183727A/ja active Pending
- 1996-12-06 CN CN96123098A patent/CN1112925C/zh not_active Expired - Fee Related
- 1996-12-06 BR BR9605895A patent/BR9605895A/pt not_active Application Discontinuation
- 1996-12-06 IL IL11977896A patent/IL119778A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MX9606131A (es) | 1997-08-30 |
| IL119778A0 (en) | 1997-03-18 |
| ATE234095T1 (de) | 2003-03-15 |
| EP0778023B1 (en) | 2003-03-12 |
| ZA9610245B (en) | 1998-06-05 |
| TW427904B (en) | 2001-04-01 |
| JPH09183727A (ja) | 1997-07-15 |
| NZ299888A (en) | 2001-02-23 |
| DE69626610T2 (de) | 2003-10-02 |
| CN1159915A (zh) | 1997-09-24 |
| AU700653B2 (en) | 1999-01-14 |
| HUP9603370A2 (en) | 1997-05-28 |
| SI0778023T1 (en) | 2003-08-31 |
| NO965238L (no) | 1997-06-09 |
| CA2192298A1 (en) | 1997-06-08 |
| HUP9603370A3 (en) | 1998-12-28 |
| AR008747A1 (es) | 2000-02-23 |
| BR9605895A (pt) | 1998-08-18 |
| KR970032856A (ko) | 1997-07-22 |
| ES2188730T3 (es) | 2003-07-01 |
| EP0778023A1 (en) | 1997-06-11 |
| NO309966B1 (no) | 2001-04-30 |
| HU9603370D0 (en) | 1997-01-28 |
| CN1112925C (zh) | 2003-07-02 |
| NO965238D0 (no) | 1996-12-06 |
| DE69626610D1 (de) | 2003-04-17 |
| IL119778A (en) | 1999-07-14 |
| SK154796A3 (en) | 1997-09-10 |
| CZ6498A3 (cs) | 1998-06-17 |
| CZ354496A3 (cs) | 1998-03-18 |
| PT778023E (pt) | 2003-06-30 |
| AU7417896A (en) | 1997-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0778023T3 (da) | Produkt indeholdende rapamycin eller udvalgte derivater deraf og en NMDA- eller AMPA-antagonist til anvendelse ved behandling af epilepsi eller Huntingtons sygdom, og anvendelse af rapamycin eller udvalgte derivater deraf..... | |
| DE69626961D1 (de) | Wegwerfkleidungsstück, verfahren und vorrichtung zu dessen herstellung | |
| HUP9800725A3 (en) | 4-benzoyl-pyrozol derivatives, process for their preparation and their use as herbicides | |
| DE69629865D1 (de) | Intraluminale medische Vorrichtung, insbesondere Blutfilter | |
| BR9601093A (pt) | Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização | |
| CY2013003I2 (el) | Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων | |
| NL1000352C2 (nl) | Elektronisch betaalsysteem met verschillende rekeneenheden, elektronisch betaalmiddel alsmede werkwijze voor elektronisch betalen. | |
| AU7419996A (en) | Device for removing toxic substances from the blood | |
| NO974572D0 (no) | Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav | |
| NO902319D0 (no) | Fremgangsmaate for aa bestemme egenskaper vedroerende stroemingsdynamikk for flerfasestroemning. | |
| NO975987D0 (no) | 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater | |
| FR2704458B1 (fr) | Ensemble de distribution de produit. | |
| PT853617E (pt) | Novos derivados de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxalinilo | |
| DE69629671D1 (de) | Netzbares produkt | |
| DE69628991D1 (de) | Schaumiges gesäuertes Nahrungsmittel und Verfahren zu dessen Herstellung | |
| NL1009113A1 (nl) | Polyaryleenaminen en werkwijze voor de bereiding ervan. | |
| FI973407L (fi) | Kirurgin takki | |
| DE59600453D1 (de) | Zinnbadbodenstein, und Verfahren zu seiner Herstellung | |
| FI962603L (fi) | Hydroksihapon tai sitä sisältävän tuotteen käyttö sekä siitä tehty valmiste | |
| DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
| KR970001346A (ko) | 3--s- 트리아진-2,4,6-옥소 또는 티오트리온 제초제 | |
| ATE220674T1 (de) | 12h-dibenzo(d,g)(1,3)dioxocin derivate | |
| DE69601211D1 (de) | Lebensmittel und verfahren zu dessen herstellung | |
| NO983492D0 (no) | 2,3-disubstituerte cyklopentanderivater, fremgangsmÕte for fremstilling derav, og medisinsk anvendelse derav | |
| DE59105948D1 (de) | 2-Amino-(fluoralkoxy-pyrimidine) und Verfahren zu ihrer Herstellung. |